A longtime shortage of a type of sterile intravenous saline is now resolved, the FDA announced Friday. Sodium chloride 0.9% injection products have been in shortage since 2018. The shortage was exacerbated when Hurricane Helene flooded a Baxter manufacturing plant in Marion, N.C. last fall what was responsible for 60% of the IV fluid in the country. The IV fluid market is made up of primarily four manufacturers: Baxter International, which makes about 60%; B. Braun Medical, which makes about 23%; along with ICU Medical and Fresenius Kabi.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
